[logo] HealthTree Foundation
more_vert
chevron_left

Managing Toxicities of T-cell Redirection

adjust

1. What types of infections have been seen with CAR-T and BsAb therapy? Why are these infections prevalent ? How are serious infections mitigated after CAR T cell and BsAb therapy? Video

bookmark_border

2. What is immune effector cell associated hematotoxicity (ICHAT)? Which myeloma therapies are associated with ICHAT? How is ICHAT managed? Video

bookmark_border

3. Is the risk of cardiac toxicity of CAR-T cell therapy? Video

bookmark_border

4. What neurotoxicities are associated with T-cell therapies? How are these toxicities managed? What is the risk of delayed toxicity? Video

bookmark_border

What types of infections have been seen with CAR-T and BsAb therapy? Why are these infections prevalent ? How are serious infections mitigated after CAR T cell and BsAb therapy?

Last year

Lesson Description

This video will go over types of infections that can be seen with CAR-T and BsAB therapies.